General Information of Drug (ID: DMMCDR7)

Drug Name
Betais-sulfonylamino derivative 1 Drug Info
Synonyms PMID28627961-Compound-40
Cross-matching ID
PubChem CID
42596932
TTD Drug ID
DMMCDR7

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
AAD-2004 DMG4RK0 Alzheimer disease 8A20 Phase 1 [2]
Carboxylic acid derivative 1 DM86E2P Angiogenesis disorder BE2Z Patented [1]
Phthalazinone derivative 1 DMNA941 N. A. N. A. Patented [1]
Benzamide derivative 18 DMD7640 N. A. N. A. Patented [1]
Benzimidazole derivative 13 DMV4DQI N. A. N. A. Patented [1]
Benzamide derivative 16 DMOAXKF N. A. N. A. Patented [1]
Imidazopyridine derivative 5 DMUKBGD N. A. N. A. Patented [1]
Imidazopyridine derivative 6 DMA0V4F N. A. N. A. Patented [1]
PMID28627961-Compound-22 DM36P7T N. A. N. A. Patented [1]
Imidazole benzamide derivative 1 DM0SOKJ Knee pain ME82 Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Prostaglandin E synthase (PTGES) TTYLQ8V PTGES_HUMAN Inhibitor [1]

References

1 Microsomal prostaglandin E2 synthase-1 inhibitors: a patent review.Expert Opin Ther Pat. 2017 Sep;27(9):1047-1059.
2 Concurrent blockade of free radical and microsomal prostaglandin E synthase-1-mediated PGE2 production improves safety and efficacy in a mouse model of amyotrophic lateral sclerosis. J Neurochem. 2012 Sep;122(5):952-61.